SGH
Sivik Global Healthcare Portfolio holdings
AUM
$224M
This Quarter Return
+1.02%
1 Year Return
+5.3%
3 Year Return
+45.33%
5 Year Return
+103.79%
10 Year Return
+430.94%
AUM
$224M
AUM Growth
+$224M
(-19%)
Cap. Flow
-$55.1M
Cap. Flow
% of AUM
-24.62%
Top 10 Holdings %
Top 10 Hldgs %
42.57%
Holding
53
New
5
Increased
12
Reduced
16
Closed
14
Top Buys
| 1 |
Merck
MRK
|
$8.16M |
| 2 |
Cencora
COR
|
$5.86M |
| 3 |
Biogen
BIIB
|
$4.63M |
| 4 |
Agilent Technologies
A
|
$4.54M |
| 5 |
Bruker
BRKR
|
$2.55M |
Top Sells
| 1 |
SPDR S&P Biotech ETF
XBI
|
$28.5M |
| 2 |
Charles River Laboratories
CRL
|
$6.77M |
| 3 |
Inspire Medical Systems
INSP
|
$5.91M |
| 4 |
Abbott
ABT
|
$5.68M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
$5.02M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Agilent Technologies
A
$35.7B
| $4.54M | 1.63% |
+35,000
| New | +$4.54M |
|
27
West Pharmaceutical
WST
$17.8B
| $4.28M | 1.54% |
13,000
+3,000
| +30% | +$988K |
|
28
Smith & Nephew
SNN
$16.3B
| $3.72M | 1.34% |
150,000
-55,000
| -27% | -$1.36M |
|
29
DexCom
DXCM
$29.5B
| $3.4M | 1.22% |
30,000
-5,000
| -14% | -$567K |
|
30
Baxter International
BAX
$12.7B
| $3.35M | 1.2% |
100,000
-30,000
| -23% | -$1M |
|
31
Teva Pharmaceuticals
TEVA
$21.1B
| $3.25M | 1.17% |
200,000
+25,000
| +14% | +$406K |
|
32
Natera
NTRA
$23.1B
| $3.25M | 1.17% |
30,000
-5,000
| -14% | -$542K |
|
33
Maravai LifeSciences
MRVI
$350M
| $3.22M | 1.16% |
450,000
+85,000
| +23% | +$609K |
|
34
Medpace
MEDP
$13.4B
| $3.09M | 1.11% |
7,500
| – | – |
|
35
Humana
HUM
$36.5B
| $2.8M | 1.01% |
7,500
-12,500
| -63% | -$4.67M |
|
|
36
Bruker
BRKR
$5.16B
| $2.55M | 0.92% |
+40,000
| New | +$2.55M |
|
37
Repligen
RGEN
$6.88B
| $1.89M | 0.68% |
+15,000
| New | +$1.89M |
|
|
38
Abbott
ABT
$231B
| – | – |
-50,000
| Closed | -$5.68M |
|
|
39
BioMarin Pharmaceuticals
BMRN
$11.2B
| – | – |
-57,500
| Closed | -$5.02M |
|
40
BioNTech
BNTX
$24B
| – | – |
-25,000
| Closed | -$2.31M |
|
41
Cigna
CI
$80.3B
| – | – |
-10,000
| Closed | -$3.63M |
|
|
42
Charles River Laboratories
CRL
$8.04B
| – | – |
-25,000
| Closed | -$6.77M |
|
43
GE HealthCare
GEHC
$33.7B
| – | – |
-40,000
| Closed | -$3.64M |
|
44
Structure Therapeutics
GPCR
$1.11B
| – | – |
-4,464
| Closed | -$191K |
|
|
45
Inspire Medical Systems
INSP
$2.77B
| – | – |
-27,500
| Closed | -$5.91M |
|
46
Option Care Health
OPCH
$4.65B
| – | – |
-110,000
| Closed | -$3.69M |
|
47
Revvity
RVTY
$10.5B
| – | – |
-30,000
| Closed | -$3.15M |
|
48
Stevanato
STVN
$6.28B
| – | – |
-83,039
| Closed | -$2.67M |
|
49
UnitedHealth
UNH
$281B
| – | – |
-10,000
| Closed | -$4.95M |
|
|
50
SPDR S&P Biotech ETF
XBI
$5.07B
| – | – |
-300,000
| Closed | -$28.5M |
|